Pharmaceuticals, Biotechnology and Life Sciences
Valneva’s subsidiary Valneva Scotland has been awarded research and development funding of up to £20 million by Scottish Enterprise. The…
Recipharm, a global contract development and manufacturing organisation (CDMO), has announced the acquisition of Vibalogics, a virotherapy CDMO and a…
Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest…
Bristol Myers Squibb (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics…
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a genome editing company focused on developing curative therapies leveraging CRISPR-based technologies, and ONK Therapeutics Ltd.,…
miDiagnostics, a POC diagnostics company backed by Belgian Family Offices, announces the success of the Brussels Airport pilot study for…
The startup company Novel Concepts Medical has announced that its novel plant-based treatment has resulted in successfully inhibiting the COVID-19…
AOP Orphan Pharmaceuticals announced that on Monday February 14, 2022 the German Federal Court of Justice decided on PEC’s challenge…
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate…
TORONTO, Feb. 15, 2022 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…